Article

Higher-risk periods for suicide among VA patients receiving depression treatment: Prioritizing suicide prevention efforts

Department of Veterans Affairs, Ann Arbor Center of Excellence (COE), Serious Mental Illness Treatment Research and Evaluation Center (SMITREC), Ann Arbor, Michigan 48113-0170, USA.
Journal of Affective Disorders (Impact Factor: 3.71). 10/2008; 112(1-3):50-8. DOI: 10.1016/j.jad.2008.08.020
Source: PubMed

ABSTRACT Health systems with limited resources may have the greatest impact on suicide if their prevention efforts target the highest-risk treatment groups during the highest-risk periods. To date, few health systems have carefully segmented their depression treatment populations by level of risk and prioritized prevention efforts on this basis.
We conducted a retrospective cohort study of 887,859 VA patients receiving depression treatment between 4/1/1999 and 9/30/2004. We calculated suicide rates for five sequential 12-week periods following treatment events that health systems could readily identify: psychiatric hospitalizations, new antidepressant starts (>6 months without fills), "other" antidepressant starts, and dose changes. Using piecewise exponential models, we examined whether rates differed across time-periods. We also examined whether suicide rates differed by age-group in these periods.
Over all time-periods, the suicide rate was 114/100,000 person-years (95% CI; 108, 120). In the first 12-week periods, suicide rates were: 568/100,000 p-y (95% CI; 493, 651) following psychiatric hospitalizations; 210/100,000 p-y (95% CI; 187, 236) following new antidepressant starts; 193/100,000 p-y (95% CI; 167, 222) following other starts; and 154/100,000 p-y (95% CI; 133, 177) following dose changes. Suicide rates remained above the base rate for 48 weeks following hospital discharge and 12 weeks following antidepressant events. Adults aged 61-80 years were at highest risk in the first 12-week periods.
To have the greatest impact on suicide, health systems should prioritize prevention efforts following psychiatric hospitalizations. If resources allow, closer monitoring may also be warranted in the first 12 weeks following antidepressant starts, across all age-groups.

Download full-text

Full-text

Available from: Daniel Eisenberg, Aug 31, 2015
0 Followers
 · 
188 Views
  • Source
    • "Some authors have suggested acute factors, such as acute anxiety, agitation, depression, anhedonia, and history of attempts, may be more predictive, however there is general agreement that prediction is difficult (Tischler & Reiss, 2009). Other empirically-based risk factors specific to psychiatric inpatients (in addition to those identified in the systematic reviews ) include: clinical demographic, family, environmental risk factors), and clinician and system failures (Bongar & Sullivan , 2013; Busch, Fawcett, & Jacobs, 2003; Harris & Barraclough , 1994; Janofsky, 2009; Mills et al., 2013; Joint Commission Sentinel Alert, GCAHO, 2004; Silverman, Berman, Bongar, & Litman, 1994; Tischler et al., 2009; Valenstein et al., 2009b; Work Group on Suicidal Behaviors, 2003). Yet, Large and colleagues (2011) conducted a meta-analysis of 29 controlled studies among psychiatric inpatients and concluded that depression and prior suicide attempt were most predictive of a high-risk categorization and subsequent suicide. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In total, 75% of suicides reported to the Joint Commission as sentinel events since 1995, have occurred in psychiatric settings. Ensuring patient safety is one of the primary tasks of inpatient psychiatric units. A review of inpatient suicide-specific safety components, inclusive of incidence and risk; guidelines for evidence based care; environmental safety; suicide risk assessment; milieu observation and monitoring; psychotherapeutic interventions; and documentation is provided. The Veterans Health Administration (VA) has been recognized as an exemplar system in suicide prevention. A VA inpatient psychiatric unit is used to illustrate the operationalization of a culture of suicide-specific safety. We conclude by describing preliminary unit outcomes and acknowledging limitations of suicide-specific inpatient care and gaps in the current inpatient practices and research on psychotherapeutic interventions, observation, and monitoring.
    Issues in Mental Health Nursing 04/2015; 36(3):190-199. DOI:10.3109/01612840.2014.961625
  • Source
    • "For instance, some antidepressants may be weakly carcinogenic (Cosgrove et al., 2011) or cause osteoporosis (Verdel et al., 2010). Antidepressants have also been associated with an increased acute risk of suicide in younger patients while they may decrease the risk of suicide in older patients or with longer-term use (Ghaemi et al., 2013; Isacsson et al., 2010; Leon et al., 2011; Valenstein et al., 2009). Also, all major classes of antidepressants have been associated with unpleasant (and sometimes dangerous) symptoms when they are discontinued abruptly (Haddad, 2001; Lader, 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Major depressive disorder (MDD) presents with a variety of symptoms and responds to a wide range of treatment interventions. Diagnostic criteria collapse multiple syndromes with distinct etiologies into the same disorder. MDD is typically understood as a malfunction of neurotransmission or brain circuitry regulating mood, pleasure and reward, or executive function. However, research from an evolutionary perspective suggests that the “normal” functioning of adaptations may also generate symptoms meeting diagnostic criteria. Functioning adaptations may be an underappreciated etiological pathway to MDD. Many adaptive functions for depressive symptoms have been suggested: biasing cognition to avoid losses, conserving energy, disengaging from unobtainable goals, signaling submission, soliciting resources, and promoting analytical thinking. We review the potential role of these adaptive functions and how they can lead to specific clusters of depressive symptoms. Understanding MDD from such a perspective reduces the heterogeneity of cases and may help to select the best intervention for each patient. We discuss the implications of different adaptive and maladaptive etiological pathways for the use of antidepressants and various modes of psychotherapy. In particular, instances of MDD caused by functioning adaptations may benefit most from treatments that support the adaptive function, or that target the precipitating causal stressor. We conclude that an evolutionary approach to the study of MDD may be one of the more promising approaches to reduce its heterogeneity and to better match patients and treatment.
    Journal of Affective Disorders 09/2014; 172. DOI:10.1016/j.jad.2014.09.032 · 3.71 Impact Factor
  • Source
    • "The dependent variable for this study was a dichotomous indicator of antidepressant adherence (adherent/ non-adherent) at 4-month follow-up. Antidepressant adherence was assessed at 4 months, as the early treatment phase is a particularly critical time period with increased risk of treatment dropout, medication discontinuation (Sirey et al., 2001a, Sirey et al., 2001b), and vulnerability to suicide (Valenstein et al., 2009). Adherence was measured using the validated self-report adherence question from the Brief Medication Questionnaire (BMQ) (Svarstad et al., 1999) that asks how consistently the subject took their medication on a daily basis in the week prior to the interview. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We examined the associations between treatment attitudes and beliefs with race-gender differences in antidepressant adherence. Subjects (n = 186) were African-American and White subjects aged ≥60 years, diagnosed with clinically significant depression, and had a new outpatient primary care recommendation for antidepressant treatment. Antidepressant adherence was assessed using the Brief Medication Questionnaire. Attitudes and beliefs were assessed using the Patients Attitudes Toward and Ratings of Care for Depression, two items rating perceived medication importance, and a modified version of the Stigma Scale for Receiving Psychological Help. African-American men and women had significantly greater concerns about antidepressants and significantly less understanding about treatment than White women. African-American men had significantly more negative attitudes toward healthcare providers than African-American and White women. African-American women were more likely than White men and women to endorse a medication other than their antidepressant as most important. Whereas some race-gender differences were found in personal spirituality, no group differences were found in perceived stigma. In a logistic regression model adjusted for key baseline variables, White women were significantly more adherent to antidepressants than African-American women (OR = 3.05, 95% CI = 1.06-8.81). Fewer concerns about antidepressants and indicating the antidepressant as the most important medication were both significantly associated with adherence. After including either of these two variables, the adherence difference between White women and African-American women was no longer significant (OR = 2.56, 95% CI = 0.84-7.80). Concerns about antidepressants and the importance of antidepressant medication are associated with adherence and are potentially modifiable through improved patient-provider communication, psycho-education, and therapeutic interventions. Copyright © 2013 John Wiley & Sons, Ltd.
    International Journal of Geriatric Psychiatry 02/2014; 29(2). DOI:10.1002/gps.3984 · 3.09 Impact Factor
Show more